PAR Sterile Products

Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.

Editors [1]

The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.

Publications [4]

The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.

Share This Page